FDA Oversight of Foreign Generic Drug Manufacturing: Standards and Compliance
Explore how the FDA monitors foreign generic drug plants, the shift to unannounced inspections, and the impact of CGMP standards on global pharmaceutical safety.
Read morePopular post
Category: Healthcare Policy & IP - Page 2
Patent Term Restoration: Legal Methods to Extend Pharmaceutical Exclusivity
Patent Term Restoration recovers time lost during FDA regulatory review. Learn how the Hatch-Waxman Act extends exclusivity, calculation rules, and strategic implications for pharma.
Read more